BRIEFING. Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition Identification B Identification C + + +

Similar documents
Change to read: BRIEFING

BRIEFING Assay + + +

MONOGRAPHS (USP) Saccharin Sodium

BRIEFING. Nonharmonized attributes: Identification, Heavy metals, Characters, Labeling, Bacterial endotoxins, Sterility, Storage.

» Monohydrate Citric Acid contains one molecule of water of hydration. It contains not less than 99.5 percent and not more than 100.

MONOGRAPHS (NF) Pharmacopeial Forum 616 HARMONIZATION Vol. 31(2) [Mar. Apr. 2005]

» Croscarmellose Sodium is a cross linked polymer of carboxymethylcellulose sodium.

BRIEFING. 1. Definition Changed to include only Wheat Starch, as to conform to the individual monograph for Wheat Starch.

BRIEFING. Nonharmonized attributes: Characters, Microbial Enumeration Tests, and Tests for Specified Microorganisms, and Packing and Storage (USP)

The Nitrofurantoin Capsules Revision Bulletin supersedes the currently official monograph.

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

6.02 Uniformity of Dosage Units

contents of the monograph in effect today. Please refer to the current edition of the USP NF for official text.

Revision Bulletin 23 Feb Mar 2018 Chemical Medicines Monographs 3 Compliance

Hydroponics TEST KIT MODEL AM-41 CODE 5406

Chemical Pharmaceutical Quality Control. Prof.Dr.Joumaa Al- Zehouri Damascus university Faculty of Pharmacy

HYDROXYPROPYLCELLULOSE, LOW SUBSTITUTED Stage 4, Revision 1 CP: USP BRIEFING NOTE

Diltiazem Hydrochloride Extended-Release Capsules. Type of Posting Posting Date Official Date

Quetiapine Tablets. Expert Committee Monographs Chemical Medicines 4 Reason for Revision Compliance

ARTESUNATE TABLETS: Final text for revision of The International Pharmacopoeia (December 2009) ARTESUNATI COMPRESSI ARTESUNATE TABLETS

European Pharmacopoeia solutions

ARTENIMOLUM ARTENIMOL. Adopted revised text for addition to The International Pharmacopoeia

Should you have any questions, please contact Heather Joyce, Ph.D., Senior Scientific Liaison ( or

Heparin Sodium ヘパリンナトリウム

Draft proposal for The International Pharmacopoeia

Petrolatum. Stage 4, Revision 1. Petrolatum is a purified semi solid mixture of hydrocarbons obtained from petroleum.

Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA

Compliance. Should you have any questions, please contact Behnaz Almasi, Associate Scientific Liaison ( or

Revision of monograph in the 4 th Edition of The International Pharmacopoeia (August 2008)

Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016.

DRAFT PROPOSAL FOR THE INTERNATIONAL PHARMACOPOEIA: CARBAMAZEPINI COMPRESSI - CARBAMAZEPINE TABLETS

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

Pectins. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 82 nd meeting 2016

Draft monograph for inclusion in. The International Pharmacopoeia. Dextromethorphani solutionum peroralum - Dextromethorphan oral solution

CYCLOSERINI CAPSULAE - CYCLOSERINE CAPSULES (AUGUST 2015)

Purity Tests for Modified Starches

Final text for addition to The International Pharmacopoeia (June 2010)

Thiols (mercaptans) in Fuels (ASTM D )

Rebaudioside a From Multiple Gene Donors Expressed in Yarrowia Lipolytica

INTERNATIONAL PHARMACOPOEIA MONOGRAPH ON LAMIVUDINE TABLETS

Tramadol Hydrochloride Extended-Release Tablets. Expert Committee Chemical Medicines Monographs 2 Reason for Revision Compliance

Hydroxypropyl Starch (Tentative)

RITONAVIRI COMPRESSI RITONAVIR TABLETS. Final text for addition to The International Pharmacopoeia (July 2012)

Telmisartan and Hydrochlorothiazide Tablets. Type of Posting. Revision Bulletin Posting Date. 26 Jan 2018 Official Date

E17 ETHYLCELLULOSE. Revision 3 Stage 4

CHAPTER 3: MATERIALS AND METHODS

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB

Should you have any questions, please contact Heather Joyce, Ph.D., Senior Scientific Liaison ( or

Revision Bulletin 28 Jul Aug 2017 Chemical Medicines Monographs 3

905 UNIFORMITY OF DOSAGE UNITS

Student Practical Guide (1) Milk of Magnesia

Lutein Esters from Tagetes Erecta

Instruction Manual Updated 8/27/2013 Ver. 1.1

contents of the currently official monograph. Please refer to the current edition of the USP NF for official text.

SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS Draft proposal for The International Pharmacopoeia (September 2010)

EXPERIMENT 4 DETERMINATION OF REDUCING SUGARS, TOTAL REDUCING SUGARS, SUCROSE AND STARCH

1 out of 8. Residue Monograph prepared by the meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), 86th Meeting 2018 ERYTHROSINE

E55A GELATIN, GELLING GRADE Gelatina

SOUTH AFRICAN NATIONAL STANDARD

Chemistry Iodometric Determination of Vitamin C

INTERIM REVISION ANNOUNCEMENT

--> Buy True-PDF --> Auto-delivered in 0~10 minutes. GB Translated English of Chinese Standard: GB1886.

Instruction Number: 5681

Title Revision n date

Hardness (Total & Calcium) Test Kit TK4040-Z 1 drop = 2 or 10 ppm as CaCO 3

THERMALLY OXIDIZED SOYA BEAN OIL interacted with MONO- and DIGLYCERIDES of FATTY ACIDS

Standard Operating Procedure for Chloride and Silica in Lake Water (Lachat Method)

LEVONORGESTREL AND ETHINYLESTRADIOL TABLETS. (January 2012) DRAFT FOR COMMENT

Methotrexate. (Ph. Eur. monograph 0560) C 20 H 22 N 8 O Action and use. Dihydrofolate reductase inhibitor; cytostatic.

REVISED DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA RETINOL CONCENTRATE, OILY FORM. (August 2010)

GB Translated English of Chinese Standard: GB NATIONAL STANDARD

Official Journal of the European Union L 51/7

Feedstuffs Analysis G-22-1 PROTEIN

ZIDOVUDINE, LAMIVUDINE AND ABACAVIR TABLETS Draft proposal for The International Pharmacopoeia (September 2006)

PROPOSAL FOR REVISION OF MONOGRAPH IN THE FOURTH EDITION OF The International Pharmacopoeia MEFLOQUINE HYDROCHLORIDE (JANUARY 2012) DRAFT FOR COMMENT

Should you have any questions, please contact Gerald Hsu, Ph.D., Senior Scientific Liaison ( or

Enzymatic Assay of ß-GLUCOSIDASE (EC )

The Tacrolimus Capsules Revision Bulletin supersedes the currently official monograph.

Dudley Chemical Corporation

DRAFT MONOGRAPH FOR THE INTERNATIONAL PHARMACOPOEIA PAEDIATRIC RETINOL ORAL SOLUTION (August 2010)

Manufacturer of High Purity Chemicals PRODUCT LIST

B. 1% (w/v) Salicin Substrate Solution (Salicin) (Prepare 50 ml in Reagent A using Salicin, Sigma Prod. No. S-0625.)

Determination of Calcium in Milk

DROP TEST SODIUM NITRITE (1 drop = 40 ppm)

INTERNATIONAL ŒNOLOGICAL CODEX. BENTONITES Bentonita N SIN: 558 (Oeno 11/2003 modified Oeno )

EXPT. 10 DETERMINATION OF ZINC BY PRECIPITATION WITH POTASSIUM FERROCYANIDE USING INTERNAL INDICATOR

COMMENTARY TO USP31 - NF26

Aim: To study the effect of ph on the action of salivary amylase. NCERT

CELLULOSE, MICROCRYSTALLINE. Cellulosum microcristallinum. Cellulose, microcrystalline EUROPEAN PHARMACOPOEIA 7.0

Challenges with Chelated &/or Complexed Minerals (Chelated and Soluble Methods of Analysis Used in FL)

No comments were received for the following proposals:

ISOMALT. Stage 4. C 12 H 24 O 11 M r C 12 H 24 O 11, 2H 2 O M r DEFINITION

Draft Indian Standard SODIUM HYDROXIDE, FOOD GRADE SPECIFICATION

Potentiometric determination. Application Bulletin 125/3 e. Branch General analytical laboratories; water analysis; beverages

By Authority Of THE UNITED STATES OF AMERICA Legally Binding Document

COMMON BARBERRY FOR HOMOEOPATHIC PREPARATIONS BERBERIS VULGARIS FOR HOMOEOPATHIC PREPARATIONS

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD ESTIMATION OF TOLVAPTAN IN BULK PHARMACEUTICAL FORMULATION

Certificates of Analysis, Material Safety Data Sheets and Pharmaceutical Compounding

Transcription:

BRIEFING Edetate Calcium Disodium, USP 29 page 779. The Japanese Pharmacopoeia is the coordinating pharmacopeia for the international harmonization of the compendial standards for the Edetate Calcium Disodium monograph, as part of the process of international harmonization of monographs and general analytical methods of the European, Japanese, and United States pharmacopeias. The following monograph, which represents the ADOPTION STAGE 6 document, is based on the corresponding monograph for Edetate Calcium Disodium that was prepared by the Japanese Pharmacopoeia. The Japanese Pharmacopoeia draft was based in part on comments from the European Pharmacopoeia and the United States Pharmacopeia in response to the Provisional Harmonized Text Stage 5A and 5B drafts prepared by the Japanese Pharmacopoeia. Differences between the Japanese Pharmacopoeia Adoption Stage 6 document and the current USP monograph for Edetate Calcium Disodium include the following: 1. Definition Changed to reflect new purity specifications (not less than 98.0%). 2. Storage Retained as a nonharmonized attribute. 3. Identification Identification test A (IR absorption) is retained as a nonharmonized attribute. Tests B and C are replaced by more definitive tests for calcium and sodium, respectively. Test B was updated to include experimental detail consistent with JP standards. Identification test C replaced the existing procedure with a pyroantimonate test to be consistent with JP standards. 4. ph No change. 5. Chloride New test added to reflect sign off draft. 6. Magnesium chelating substances Renamed as Disodium edetate. Changed to reflect decrease in sample concentration, and titrant changed to magnesium chloride to be consistent with JP. 7. Water Updated specification to include lower limit of 5.0% to be consistent with JP. 8. Heavy metals Retained as a nonharmonized attribute. 9. Limit of nitrilotriacetic acid Retained as a nonharmonized attribute. 10. Assay Procedure changed to harmonize with JP and EP standards. Decreased sample size to 0.5 g and increased volume of water in test solution to 200 ml. Changed titrant to bismuth nitrate and indicator to xylenol orange to eliminate use of mercuric nitrate. (MD GRE: K. Moore) RTS C44011 Edetate Calcium Disodium Pharmacopeial Discussion Group Sign Off Document Attributes EP JP USP Definition + + + Identification B + + + Identification C + + + http://www.usppf.com/pf/pub/index.html 1/5

Attributes EP JP USP ph + + + Purity (1) Chloride + + + Purity (2) Disodium edetate + + + Water + + + Assay + + + Legend: + will adopt and implement; will not stipulate. Nonharmonized attributes: Clarity and/or color of solution, Heavy metals, Identification by IR absorption, Limit of nitrilotriacetic acid, Storage. Specific local attributes: Description (JP), Iron (EP). C 10 H 12 CaN 2 Na 2 O 8 x H 2 O 374.27 Calciate (2 ), [[N,N 1,2 ethanediylbis[n (carboxymethyl)glycinato]](4 ) N,N,O,O,O N,O N ], disodium, hydrate, (OC 6 21). Disodium[(ethylenedinitrilo)tetraacetato]calciate(2 ) hydrate [23411 34 9]. Anhydrous [62 33 9].» Edetate Calcium Disodium is a mixture of the dihydrate and trihydrate of calcium disodium ethylenediaminetetraacetate (predominantly the dihydrate). It contains not less than 97.0 percent and not more than 102.0 percent of C 10 H 12 CaN 2 Na 2 O 8, calculated on the anhydrous basis. http://www.usppf.com/pf/pub/index.html 2/5

» Edetate Calcium Disodium contains not less than 98.0 percent and not more than 102.0 percent of C 10 H 12 CaN 2 Na 2 O 8 (374.27), calculated on the anhydrous basis. Packaging and storage Preserve in tight containers. Packaging and storage Preserve in tight containers. No storage requirements specified. USP Reference standards 11 USP Edetate Calcium Disodium RS. Identification A: Infrared Absorption 197M. B: A solution (1 in 20) responds to the oxalate test for Calcium 191 and to the flame test for Sodium 191. C: To 5 ml of water add 2 drops of ammonium thiocyanate TS and 2 drops of ferric chloride TS. To the deep red solution add about 50 mg of Edetate Calcium Disodium, and mix: the deep red color disappears. Identification A: Infrared Absorption 197M. B: Dissolve 2 g in 10 ml of water, add 6 ml of lead (II) nitrate solution (33 in 1000), shake, and add 3 ml of potassium iodide TS: no yellow precipitate is formed. Make this solution alkaline by the addition of diluted ammonia solution (7 in 50), and add 3 ml of ammonium oxalate TS: a white precipitate is formed. C: Dissolve 0.5 g in 10 ml of water, and add 10 ml of potassium pyroantimonate TS: a white, crystalline precipitate is formed. The formation of the precipitate is accelerated by rubbing the inside wall of the test tube with a glass rod. ph 791 : between 6.5 and 8.0, in a solution (1 in 5). Chloride 221 To 0.70 g add 20 ml of water and 30 ml of diluted nitric acid, allow to stand for 30 minutes, and filter. To 10 ml of the filtrate add water to make 50 ml, and perform the test using this solution as the test solution. Prepare the control solution with 0.40 ml of 0.01 M hydrochloric acid VS (not more than 0.10%). http://www.usppf.com/pf/pub/index.html 3/5

Magnesium chelating substances Weigh accurately 1.0 g, transfer to a small beaker, and dissolve in 5 ml of water. Add 5 ml of ammonia ammonium chloride buffer TS. Then to the buffered solution add 5 drops of eriochrome black TS, and titrate with 0.10 M magnesium acetate to the appearance of a deep wine red color: not more than 2.0 ml is required. Disodium edetate Dissolve 1.00 g of Edetate Calcium Disodium in 50 ml of water, add 5 ml of ammonia ammonium chloride buffer TS, and 40 mg of eriochrome black T sodium chloride indicator. Titrate with 0.01 M magnesium chloride VS until the color of the solution changes from blue to red violet: not more than 3.0 ml of 0.01 M magnesium chloride VS is consumed (not more than 1.0%). Water, Method I 921 : not more than 13.0%. Water, Method I 921 : between 5.0% and 13.0%, determined on 0.2 g. Heavy metals, Method II 231 : 0.002%. Limit of nitrilotriacetic acid Mobile phase, Cupric nitrate solution, Stock standard solution, and Chromatographic system Prepare as directed in the test for Limit of nitrilotriacetic acid under Edetate Disodium. Resolution solution Using Edetate Calcium Disodium instead of Edetate Disodium,prepare as directed for Resolution solution in the test for Limit of nitrilotriacetic acid under Edetate Disodium. Standard solution Transfer 1.0 g of Edetate Calcium Disodium to a 100 ml volumetric flask, add 100 µl of Stock standard solution,dilute with Cupric nitrate solution to volume, and mix. Sonicate, if necessary, to achieve complete solution. Test solution Transfer 1.0 g of Edetate Calcium Disodium to a 100 ml volumetric flask, dilute with Cupric nitrate solution to volume, and mix. Sonicate, if necessary, to achieve complete solution. Procedure Proceed as directed for Procedure in the test for Limit of nitrilotriacetic acid under Edetate Disodium:the response of the nitrilotriacetic acid peak of the Test solutiondoes not exceed the difference between the nitrilotriacetic acid peak responses obtained from the Standard solutionand the Test solution (0.1%). Residual solvents 467 : meets the requirements. (Official January 1, 2007) http://www.usppf.com/pf/pub/index.html 4/5

Assay Weigh accurately about 1.2 g of Edetate Calcium Disodium, transfer to a 250 ml beaker, and dissolve in 75 ml of water. Add 25 ml of 1 N acetic acid and 1 ml of diphenylcarbazone TS, and titrate slowly with 0.1 M mercuric nitrate VS to the appearance of the first purplish color. Perform a blank determination, and make any necessary correction. Each ml of 0.1 M mercuric nitrate is equivalent to 37.43 mg of C 10 H 12 CaN 2 Na 2 O 8. Assay Transfer about 500 mg of Edetate Calcium Disodium, accurately weighed, into a 200 ml volumetric flask. Dissolve in and dilute with water to volume, and mix. Transfer exactly 20 ml of this solution to 80 ml of water, and adjust with dilute nitric acid to a ph of 2 to 3. Add two drops of xylenol orange TS, and titrate with 0.01 M bismuth nitrate VS until the color of the solution changes from yellow to red. Each ml of 0.01 M bismuth nitrate VS is equivalent to 3.743 mg of C 10 H 12 CaN 2 Na 2 O 8. Auxiliary Information Staff Liaison : Elena Gonikberg, Ph.D., Senior Scientist Expert Committee : (MDGRE05) Monograph Development Gastrointestinal Renal and Endocrine USP29 NF24 Page 779 Pharmacopeial Forum : Volume No. 32(4) Page 1335 Phone Number : 1 301 816 8251 http://www.usppf.com/pf/pub/index.html 5/5